Sodium channel blockers
AssigneeDaewoong Pharmaceutical Co., Ltd.
InventorsJi Duck Kim, Hyung Geun Lee, Inwoo Kim, Sun Ah Jun, Myunggi Jung, Hyo Shin Kim
Life of this patent
Estimating the term…
Loading patent…
AssigneeDaewoong Pharmaceutical Co., Ltd.
InventorsJi Duck Kim, Hyung Geun Lee, Inwoo Kim, Sun Ah Jun, Myunggi Jung, Hyo Shin Kim
Estimating the term…
The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and use thereof. The compound represented by the Formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof can be effectively used in the prevention or treatment of pains, for example, acute pain, chronic pain, pain from nervous disease, postoperative pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, paroxysmal extreme pain disorder (PEPD).
A compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof:
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of
Dependencies are inferred from the claim text.